ROPLAS is Superior to Syringing for Dacryocystitis Diagnosis
ROPLAS (Regurgitation On Pressure over the Lacrimal Sac) is superior to syringing for diagnosing dacryocystitis due to its high sensitivity (93.2%) and specificity (99.3%), while avoiding the invasiveness and potential complications of syringing.
Comparison of ROPLAS vs. Syringing
ROPLAS Advantages
- Non-invasive diagnostic technique
- High sensitivity (93.2%) and specificity (99.3%) 1
- Excellent negative predictive value (99.5%) 1
- No risk of introducing infection or trauma
- Can be performed quickly in office setting
- Does not require specialized equipment
Syringing Disadvantages
- Invasive procedure with risk of:
- Trauma to nasolacrimal system
- Potential introduction of infection
- Patient discomfort
- Requires specialized equipment and training
- More time-consuming
Diagnostic Algorithm for Dacryocystitis
Initial Assessment: Perform ROPLAS test
- If positive (regurgitation observed): Confirms chronic dacryocystitis
- If negative: Dacryocystitis unlikely (99.5% negative predictive value)
When to Consider Syringing:
- Only when ROPLAS findings are equivocal
- When index of suspicion remains high despite negative ROPLAS
- For therapeutic purposes (not just diagnostic)
Treatment Considerations
The treatment approach should be based on whether the dacryocystitis is acute or chronic:
Acute Dacryocystitis
- Systemic antibiotics based on local resistance patterns
- Consider levofloxacin or amoxicillin/clavulanate as empiric therapy 2
- In severe cases, consider incision and drainage with direct application of antibiotics inside the infected sac 3
- Obtain cultures to guide antibiotic therapy, as up to one-third of cases may have resistant organisms 2
Chronic Dacryocystitis
- Surgical intervention often required (dacryocystorhinostomy)
- Medical management with warm compresses and eyelid hygiene may provide symptomatic relief 4
Special Considerations for Pediatric Patients
For pediatric patients with dacryocystitis:
- Not all cases require hospitalization (31% resolve without admission) 5
- Not all cases require early surgical intervention (56% resolve without it) 5
- Tailor treatment individually based on severity and presentation 5
Clinical Pearls and Pitfalls
- Pearl: ROPLAS is a simple, cost-effective screening test that can reduce unnecessary syringing procedures
- Pitfall: Relying solely on syringing without considering ROPLAS exposes patients to unnecessary risks
- Pearl: Obtaining cultures at the time of empiric antibiotic initiation is valuable due to high rates of antibiotic resistance 2
- Pitfall: Assuming a specific antibiotic will be effective without culture data may lead to treatment failure in up to one-third of patients 2
In conclusion, ROPLAS should be the first-line diagnostic approach for suspected dacryocystitis, with syringing reserved for specific indications when ROPLAS is inconclusive or when therapeutic intervention is needed.